📅 IPO Launch Date and Subscription Window
Indogulf Biosciences Limited is all set to open its initial public offering (IPO) for public subscription on June 26, 2024, and will remain open until June 28, 2024. This SME IPO is expected to attract attention from retail and HNI investors interested in the pharmaceutical and life sciences sector.
💰 Price Band and Lot Size
The IPO has been priced within a band of ₹105 to ₹111 per equity share, allowing investors to participate in the offering at an affordable entry point. The minimum application size is one lot, which comprises 1,200 shares, making the minimum investment approximately ₹133,200 at the upper price band.
🏢 Company Background
Indogulf Biosciences is a fast-growing biotechnology and pharmaceutical company engaged in the development and distribution of high-quality agrochemical products, specialty chemicals, and biotechnology research tools. With a strong presence in domestic and select international markets, the company has carved a niche in crop protection and bioscience R&D.
📈 IPO Objectives
The company aims to utilize the proceeds from the IPO to:
- Support working capital requirements
- Fund expansion and marketing activities
- Strengthen corporate infrastructure
- Cover general corporate purposes
This capital infusion is expected to enhance the company’s ability to scale operations and meet growing market demand.
🧾 Financial Overview
In the past fiscal year, Indogulf Biosciences reported robust growth in revenue and profitability. Strong fundamentals and consistent performance have positioned the company as a promising candidate in the SME IPO space. According to its DRHP filing, the company witnessed significant year-on-year growth in turnover and EBITDA margins.
📊 GMP and Market Buzz
Market observers report that the grey market premium (GMP) for Indogulf Biosciences IPO is currently ranging between ₹18–₹25 per share, indicating positive sentiment among investors. While GMP is not a guaranteed indicator of listing performance, it does reflect early demand trends and market perception.
📍 IPO Details at a Glance
| Particulars | Details |
|---|---|
| IPO Opening Date | June 26, 2024 |
| IPO Closing Date | June 28, 2024 |
| Price Band | ₹105 – ₹111 per share |
| Lot Size | 1,200 shares |
| Minimum Investment Amount | ₹133,200 (at upper band) |
| Listing Platform | NSE SME |
| Registrar | Skyline Financial Services Pvt Ltd |
📝 Expert Insights
Market analysts believe that Indogulf Biosciences’ diverse product portfolio, established distribution network, and consistent growth make it a credible IPO in the SME segment. Investors with moderate risk appetite looking for growth-oriented exposure may consider evaluating the offering after reviewing the company’s financials and sector outlook.
💬 Have Your Say!
Are you considering investing in the Indogulf Biosciences IPO?
Do you believe the biotech and agrochemical sector offers long-term value?
📢 Share your thoughts, insights, or questions in the comments below!
❓ Frequently Asked Questions (FAQs)
Q1. What are the dates for the Indogulf Biosciences IPO?
The IPO opens on June 26, 2024, and closes on June 28, 2024.
Q2. What is the price band for this IPO?
The price band is fixed between ₹105 and ₹111 per share.
Q3. What is the minimum lot size for application?
Retail investors must apply for a minimum of 1 lot = 1,200 shares.
Q4. Will the shares be listed on the main exchange or SME platform?
Indogulf Biosciences shares will be listed on the NSE SME platform.
Q5. What will the IPO proceeds be used for?
The funds will be utilized for working capital, corporate expenses, and business expansion.
